Ruth McBride

home / authors / ruth-mcbride

Ruth McBride, BS, is chief technology officer with Axio Research Corporation, a division of Solutia Pharmaceutical Services Division, 2601 4th Avenue, Suite 200, Seattle, WA, 98121, (206) 577-0217, fax (206) 547-4671, email: davidk@axioresearch.com.

Articles

peerreview-New-1444409584605.jpeg

Evaluating the Effects of Therapy Masking

October 1st 2015

Using a specific trial, the importance of assessing the success of therapy masking is examined.

Ricker3.png

Evaluating the Effects of Therapy Masking

March 13th 2015

An important criterion for a well-conducted clinical trial is minimization of bias in endpoint assessment.

© 2024 MJH Life Sciences

All rights reserved.